aNK for Infusion: Clinical Trials

1 trial of aNK for Infusion, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1
Phase 21Terminated 1

Follow aNK for Infusion: new trials by email Literature Review of aNK for Infusion trials Research Report on aNK for Infusion

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
Cyclophosphamide, Oxaliplatin, Capecitabine - Pancreatic Cancer
Phase 1 / Phase 2TerminatedImmunityBio, Inc.32017-08-112024-06-11

Conditions studied

Pancreatic Neoplasms (1)

Sponsors

ImmunityBio, Inc. (1)

Countries

United States (1)